Showing results (51-60 of 990) with videos related to
Sort By:
Pageof 99
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
Adjuvant therapy in the elderly: making the right decisionHyman B Muss, Laura Biganzoli, Daniel J Sargent, et al.Clinical Trials (London, England)|August 3, 2017
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity dataJun Yin, Xavier Paoletti, Daniel J Sargent, et al.Statistics in Medicine|November 6, 2007
A false-discovery-rate-based loss framework for selection of interactionsWei Chen, Debashis Ghosh, Trivellore E Raghunathan, et al.Biometrics|August 16, 2011
Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific timeStuart G Baker, Daniel J Sargent, Marc Buyse, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Raising the bar for antineoplastic agents: how to choose threshold values for superiority trials in advanced solid tumorsAlberto F Sobrero, Alessandro Pastorino, Daniel J Sargent, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Role of sensitivity analyses in assessing progression-free survival in late-stage oncology trialsSuman Bhattacharya, Gwen Fyfe, Robert J Gray, et al.Journal of Biopharmaceutical Statistics|November 8, 2018
An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cyclesYu Du, Jun Yin, Daniel J Sargent, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Clinical trial designs for predictive marker validation in cancer treatment trialsDaniel J Sargent, Barbara A Conley, Carmen Allegra, et al.Biometrics|February 13, 2009
Bayesian variable selection with joint modeling of categorical and survival outcomes: an application to individualizing chemotherapy treatment in advanced colorectal cancerWei Chen, Debashis Ghosh, Trivellore E Raghunathan, et al.Discovery Medicine|April 3, 2012
Biomarkers, subgroup evaluation, and clinical trial designStuart G Baker, Barnett S Kramer, Daniel J Sargent, et al.Pageof 99